Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion

Journal of Molecular Endocrinology

Volumn 48, Issue 2, 2012, Pages 151-158

  Zhang, Hongjie ^a,b   Li, Jing ^a   Liang, Xiangying ^a   Luo, Yun ^a   Zen, Ke ^a   Zhang, Chen Yu ^a  

^a NANJING UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; SMALL INTERFERING RNA; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL STRAIN; CONTROLLED STUDY; ENTEROENDOCRINE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL MUCOSA; GENETIC TRANSFECTION; ILEUM; IMMUNOFLUORESCENCE TEST; INSULIN RELEASE; INTESTINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WILD TYPE;

ANIMALS; CELL LINE; CHOLAGOGUES AND CHOLERETICS; ENTEROENDOCRINE CELLS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; ILEUM; INTESTINAL MUCOSA; ION CHANNELS; IRIDOIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; MITOCHONDRIAL PROTEINS; RNA, SMALL INTERFERING;

EID: 84863366517     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0114     Document Type: Article

References (37)

1. Balks HJ, Holst JJ, von zur Muhlen A & Brabant G 1997 Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. Journal of Clinical Endocrinology and Metabolism 82 786-790. (doi:10.1210/jc.82.3.786)
2. Dhanvantari S & Brubaker PL 1998 Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion. Endocrinology 139 1630-1637. (doi:10.1210/en.139.4.1630)
3. Donley VR, Hiskett EK, Kidder AC & Schermerhorn T 2005 ATP-sensitive potassium channel (KATP channel) expression in the normal canine pancreas and in canine insulinomas. BMC Veterinary Research 1 8. (doi:10.1186/1746-6148-1-8)
4. Elrick H, Stimler L, Hlad CJ Jr & Arai Y 1964 Plasma insulin response to oral and intravenous glucose administration. Journal of Clinical Endocrinology and Metabolism 24 1076-1082. (doi:10.1210/jcem-24-10-1076)
5. Fehmann HC, Goke R & Goke B 1995 Cell and molecular-biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide. Endocrine Reviews 16 390-410. (doi:10.1210/edrv-16-3-390)
6. Goke R, Fehmann HC & Goke B 1991 Glucagon-like peptide-1 (7-36) amide is a new incretin/enterogastrone candidate. European Journal of Clinical Investigation 21 135-144. (doi:10.1111/j.1365-2362.1991.tb01802.x)
7. Gribble FM, Williams L, Simpson AK & Reimann F 2003 A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52 1147-1154. (doi:10.2337/diabetes.52.5.1147)
8. Hansen L 2004 Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. Regulatory Peptides 118 11-18. (doi:10.1016/j.regpep.2003.10.021)
9. Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R & Gooke B 1995 Glucagon-like peptide-1 and glucose dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56 117-126. (doi:10.1159/000201231)
10. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S & Tsujimoto G 2005 Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Medicine 11 90-94. (doi:10.1038/nm1168)
11. Holst JJ 2007 The physiology of glucagon-like peptide 1. Physiological Reviews 87 1409-1439. (doi:10.1152/physrev.00034.2006)
12. Jezek P 2002 Possible physiological roles of mitochondrial uncoupling proteins - UCPn. International Journal of Biochemistry & Cell Biology 341190-1206. (doi:10.1016/S1357-2725(02)00061-4)
13. Kim BJ, Carlson OD, Jang HJ, Elahi D, Berry C & Egan JM 2005 Peptide YY is secreted after oral glucose administration in a gender-specific manner. Journal of Clinical Endocrinology and Metabolism 90 6665-6671. (doi:10.1210/jc.2005-0409)
14. Knudsen JB, Holst JJ, Asnaes S & Johansen A 1975 Identification of cells with pancreatic-type and gut-type glucagon immunoreactivity in the human colon. Acta Pathologica et Microbiologica Scandinavica 83741-743. (doi:10.1111/j.1699-0463.1975.tb01407.x)
15. Lameloise N, Muzzin P, Prentki M & Assimacopoulos-Jeannet F 2001 Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-stimulated insulin secretion? Diabetes 50 803-809. (doi:10.2337/diabetes.50.4.803)
16. C-glucose cotransporter 1. PNAS 104 15075-15080. (doi:10.1073/pnas.0706678104)
17. Mattiasson G & Sullivan PG 2006 The emerging functions of UCP2 in health, disease, and therapeutics. Antioxidants & Redox Signaling 8 1-38. (doi:10.1089/ars.2006.8.1)
18. McIntyre N, Holdsworth CD & Turner DS 1964 New interpretation of oral glucose tolerance. Lancet 41 20-21. (doi:10.1016/S0140-6736(64)90011-X)
19. McIntyre N, Holdsworth CD & Turner DS 1965 Intestinal factors in the control of insulin secretion. Journal of Clinical Endocrinology and Metabolism 25 1317-1324. (doi:10.1210/jcem-25-10-1317)
20. Meier JJ & Nauck MA 2005 Glucagon-like peptide 1 (GLP-1) in biology and pathology. Diabetes Metabolism Research and Reviews 21 91-117. (doi:10.1002/dmrr.538)
21. Nedergaard J & Cannon B 2003 The 'novel"uncoupling' proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions Experimental Physiology 88 65-84. (doi:10.1113/eph8802502)
22. Nielsen LB, Ploug KB, Swift P, Ørskov C, Jansen-Olesen I, Chiarelli F, Holst JJ, Hougaard P, Porksen S, Holl R et al. 2007 Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes. European Journal of Endocrinology 156 663-671. (doi:10.1530/EJE-06-0756)
23. Perley MJ & Kipnis DM 1967 Plasma insulin responses to oral and intravenous glucose. Journal of Clinical Investigation 46 1954-1962. (doi:10.1172/JCI105685)
24. Reimann F, Ward PS & Gribble FM 2006 Signalling mechanisms underlying the release of glucagon-like peptide-1. Diabetes 55 (Suppl 2) S78-S85. (doi:10.2337/db06-S010)
25. Reimer RA, Darimont C, Gremlich S, Nicolas-Metral V, Ruegg UT & Mace K 2001 A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology 142 4522-4528. (doi:10.1210/en.142.10.4522)
26. Ricqier C & Bouillaud F 2000 The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochemical Journal 345 161-179. (doi:10.1042/0264-6021:3450161)
27. Ritzel U, Fromme A, Ottleben M, Leonhardt U & Ramadori G 1997 Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetologia 34 18-21. (doi:10.1007/s005920050059)
28. Rorsman P 1997 The pancreatic b-cell as a fuel sensor: an electrophysiologist's viewpoint. Diabetologia 40 487-495. (doi:10.1007/s001250050706)
29. Rousset S, Mozo J, Dujardin G, Emre Y, Masscheleyn S, Ricquier D & Cassard-Doulcier AM 2007 UCP2 is a mitochondrial transporter with an unusual very short half-life. FEBS Letters 581 479-482. (doi:10.1016/j.febslet.2007.01.010)
30. Rozengurt E & Sternini C 2007 Taste receptor signaling in the mammalian gut. Current Opinion in Pharmacology 7 557-562. (doi:10.1016/j.coph.2007.10.002)
31. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R & Goke B 1996 Gastric emptying and release of incretin hormones after glucose ingestion in humans. Journal of Clinical Investigation 97 92-103. (doi:10.1172/JCI118411)
32. Theodorakis MJ, Carlson O, Muller DC & Egan JM 2004 Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance. Diabetes Care 271692-1698. (doi:10.2337/diacare.27.7.1692)
33. Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K & Egan JM 2006 Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. American Journal of Physiology. Endocrinology and Metabolism 290 E550-E559. (doi:10.1152/ajpendo.00326.2004)
34. Thorens B 1995 Glucagon-like peptide-1 and control of insulin-secretion. Diabète & Métabolisme 21 311-318.
35. Vilsboll T & Holst JJ 2004 Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 47 357-366. (doi:10.1007/s00125-004-1342-6)
36. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB et al. 2001 Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105 745-755. (doi:10.1016/S0092-8674(01)00378-6)
37. Zhang CY, Parton LE, Ye CP, Krauss S, Shen R, Lin CT, Porco JA Jr & Lowell BB 2006 Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity-and high glucose-induced b cell dysfunction in isolated pancreatic islets. Cell Metabolism 3 417-427. (doi:10.1016/j.cmet.2006.04.010)